Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

777.11 -9.91 (-1.26%)
Streaming Delayed Price Updated: 2:00 PM EDT, May 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,226,972
Open 784.71
Bid (Size) 776.84 (1)
Ask (Size) 777.28 (4)
Prev. Close 787.02
Today's Range 773.62 - 786.48
52wk Range 434.34 - 800.78
Shares Outstanding N/A
Dividend Yield 0.58%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Eli Lilly's Weekly Insulin Dose On Par With Commonly Used Daily Doses, Phase 3 Studies Show
Eli Lilly phase 3 trials reveal once-weekly insulin efsitora as a non-inferior alternative to daily basal insulins for type 2 diabetes. 
Via Benzinga
The Dividend Investor’s Playbook: 3 Stocks for Consistent Cash Flow in 2024
Dive into dividend stocks to buy, featuring Walmart's robust earnings and Eli Lilly's advances in pharmaceuticals and WMT's stock split. 
Via InvestorPlace

Performance

YTD
+31.22%
+31.22%
1 Month
+3.51%
+3.51%
3 Month
+2.61%
+2.61%
6 Month
+32.04%
+32.04%
1 Year
+71.19%
+71.19%

More News

Read More
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
These 2 No-Brainer Growth Stocks Are Breaking New Ground
Via The Motley Fool
Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade
Via InvestorPlace
Topics Intellectual Property
Exposures Intellectual Property
Is Eli Lilly's Latest Deal a Gamechanger?
Via The Motley Fool
1 No-Brainer Growth Stock to Buy and Hold
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Wall Street Favorites: 3 Growth Stocks With Strong Buy Ratings for May 2024
Via InvestorPlace
No Wegovy Shortage in Denmark Amid High Demand, Novo Nordisk Confirms
Via Benzinga
Eli Lilly Strikes Deal To Combat Counterfeit Diabetes And Weight Loss Drugs Mounjaro And Zepbound
Via Benzinga
These 2 Words Explain Why Eli Lilly Stock Is a Buy Right Now
Via The Motley Fool
2 Top Pharma Stocks That Just Keep Getting Better and Better
Via The Motley Fool
Biotech Behemoths: 3 Giants Set to Dominate the Health Scene
Via InvestorPlace
3 Magnificent Stocks That Are Passive Income Machines
Via The Motley Fool
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Via Benzinga
Exposures COVID-19
How Viking Therapeutics Stock Could 30x
Via The Motley Fool
The Must-Watch List: 3 Stocks to Snap Up as Soon as They Hit Bargain Territory
Via InvestorPlace
Healthcare And Biotech Investing 101: What You Need To Know.
Via Talk Markets
Topics Stocks
Exposures US Equities
MarketBeat Week in Review – 5/6 - 5/10
Via MarketBeat
Topics Economy
Exposures Interest Rates
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Via The Motley Fool
SPDR ETF Report For Friday, May 10
Via Talk Markets
Topics ETFs
Highest And Lowest Price To Sales (P/S) Ratios
Via Talk Markets
Topics Stocks
Exposures US Equities
3 Biotech Stocks to Sell in May Before They Crash & Burn
Via InvestorPlace
Can Weight Loss Companies Fuel Gains In Your Stock Portfolio?
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.